Ward C - Search Results

1

Predictive markers of endocrine response in breast cancer.

Mosly D, Turnbull A, Sims A, Ward C, Langdon S. Mosly D, et al. Among authors: ward c. World J Exp Med. 2018 Aug 30;8(1):1-7. doi: 10.5493/wjem.v8.i1.1. eCollection 2018 Aug 30. World J Exp Med. 2018. PMID: 30191138 Free PMC article.

2

Inhibition of pH regulation as a therapeutic strategy in hypoxic human breast cancer cells.

Meehan J, Ward C, Turnbull A, Bukowski-Wills J, Finch AJ, Jarman EJ, Xintaropoulou C, Martinez-Perez C, Gray M, Pearson M, Mullen P, Supuran CT, Carta F, Harrison DJ, Kunkler IH, Langdon SP. Meehan J, et al. Among authors: ward c. Oncotarget. 2017 Jun 27;8(26):42857-42875. doi: 10.18632/oncotarget.17143. Oncotarget. 2017. PMID: 28476026 Free PMC article.

3

HER2 regulates HIF-2α and drives an increased hypoxic response in breast cancer.

Jarman EJ, Ward C, Turnbull AK, Martinez-Perez C, Meehan J, Xintaropoulou C, Sims AH, Langdon SP. Jarman EJ, et al. Among authors: ward c. Breast Cancer Res. 2019 Jan 22;21(1):10. doi: 10.1186/s13058-019-1097-0. Breast Cancer Res. 2019. PMID: 30670058 Free PMC article.

4

New strategies for targeting the hypoxic tumour microenvironment in breast cancer.

Ward C, Langdon SP, Mullen P, Harris AL, Harrison DJ, Supuran CT, Kunkler IH. Ward C, et al. Cancer Treat Rev. 2013 Apr;39(2):171-9. doi: 10.1016/j.ctrv.2012.08.004. Epub 2012 Oct 12. Cancer Treat Rev. 2013. PMID: 23063837 Review.

5

A comparative analysis of inhibitors of the glycolysis pathway in breast and ovarian cancer cell line models.

Xintaropoulou C, Ward C, Wise A, Marston H, Turnbull A, Langdon SP. Xintaropoulou C, et al. Among authors: ward c. Oncotarget. 2015 Sep 22;6(28):25677-95. doi: 10.18632/oncotarget.4499. Oncotarget. 2015. PMID: 26259240 Free PMC article.

6

Technical innovation in adjuvant radiotherapy: Evolution and evaluation of new treatments for today and tomorrow.

Kunkler IH, Ward C, Langdon SP. Kunkler IH, et al. Among authors: ward c. Breast. 2015 Nov;24 Suppl 2:S114-9. doi: 10.1016/j.breast.2015.07.026. Epub 2015 Oct 1. Breast. 2015. PMID: 26429399 Review.

7

Antitumour activity of the novel flavonoid Oncamex in preclinical breast cancer models.

Martínez-Pérez C, Ward C, Turnbull AK, Mullen P, Cook G, Meehan J, Jarman EJ, Thomson PI, Campbell CJ, McPhail D, Harrison DJ, Langdon SP. Martínez-Pérez C, et al. Among authors: ward c. Br J Cancer. 2016 Apr 12;114(8):905-16. doi: 10.1038/bjc.2016.6. Epub 2016 Mar 31. Br J Cancer. 2016. PMID: 27031849 Free PMC article.

8

Expression of glycolytic enzymes in ovarian cancers and evaluation of the glycolytic pathway as a strategy for ovarian cancer treatment.

Xintaropoulou C, Ward C, Wise A, Queckborner S, Turnbull A, Michie CO, Williams ARW, Rye T, Gourley C, Langdon SP. Xintaropoulou C, et al. Among authors: ward c. BMC Cancer. 2018 Jun 5;18(1):636. doi: 10.1186/s12885-018-4521-4. BMC Cancer. 2018. PMID: 29866066 Free PMC article.

9

Development and characterisation of acquired radioresistant breast cancer cell lines.

Gray M, Turnbull AK, Ward C, Meehan J, Martínez-Pérez C, Bonello M, Pang LY, Langdon SP, Kunkler IH, Murray A, Argyle D. Gray M, et al. Among authors: ward c. Radiat Oncol. 2019 Apr 15;14(1):64. doi: 10.1186/s13014-019-1268-2. Radiat Oncol. 2019. PMID: 30987655 Free PMC article.

10

Carbonic Anhydrase IX (CAIX), Cancer, and Radiation Responsiveness.

Ward C, Meehan J, Gray M, Kunkler IH, Langdon SP, Argyle DJ. Ward C, et al. Metabolites. 2018 Feb 10;8(1):13. doi: 10.3390/metabo8010013. Metabolites. 2018. PMID: 29439394 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,316 results

Search Page